Absorbable stent for recurrent tear duct infection
Part of Ear, nose & throat clinical trials.
This trial tests a new type of dissolvable stent that slowly releases medicine to treat chronic tear duct infections that have come back after previous surgery. It may help people who need another treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with long-term tear duct infection (chronic dacryocystitis).
- You have had a prior surgery for this infection that did not work or the problem returned.
- An imaging test shows your tear duct sac is at least 4 millimeters wide.
- You are 18 years old or older.
- You can understand and agree to the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a surgery called dacryocystorhinostomy (DCR) that creates a new tear drainage path to stop watery eyes. The surgery is done without a stent (a small tube), and the goal is to relieve symptoms of blocked tear ducts.
This study tests if adding a medicine called 5-FU to standard tear duct surgery helps people with a small tear drainage sac get better results. It might be an option if you have a blocked tear duct and a very small sac.
This study compares two treatments used during a surgery to unblock the tear duct. The goal is to see which one helps keep the duct open longer and reduces the chance of the blockage returning.
This trial tests whether using four balloon inflation points during tear duct surgery works better than the standard two points for people with blocked tear ducts. It aims to improve tear drainage and reduce symptoms.
This study tests a new sinus stent that slowly releases medication to treat chronic sinusitis. It may reduce symptoms and help avoid repeated surgeries.
This study tests a temporary gel for the tear ducts that may help reduce dry eye symptoms after cataract surgery. If you qualify, you'll receive the gel in both eyes and be monitored to see if it improves comfort.
Hear when a new Chronic Dacryocystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.